A European study in people with the participation of Clínic-IDIBAPS shows that treatment with the drug Abatacept reduces the risk of developing rheumatoid arthritis

by Fundació Clínic per a la Recerca Biomèdica

Published in the journal The Lancet, the study presents the results of Abatacept, a drug that modulates the activation of T cells, which play a key role in the progression of the disease.

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un ensayo de microscopía dinámica del ...

by CSIC - Centro Superior de Investigaciones Científicas

La revista ‘Nature Protocols’ selecciona esta técnica como “pro...

Photos Stream